Biomerica BMRA Stock
Biomerica Price Chart
Biomerica BMRA Financial and Trading Overview
| Biomerica stock price | 0.83 USD |
| Previous Close | 1.59 USD |
| Open | 1.63 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1000 |
| Day's Range | 1.61 - 1.67 USD |
| 52 Week Range | 1.08 - 5.25 USD |
| Volume | 27.16K USD |
| Avg. Volume | 40.48K USD |
| Market Cap | 27.92M USD |
| Beta (5Y Monthly) | -0.637676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.38 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13 USD |
BMRA Valuation Measures
| Enterprise Value | 25.76M USD |
| Trailing P/E | N/A |
| Forward P/E | 4.25641 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.9291742 |
| Price/Book (mrq) | 3.7387385 |
| Enterprise Value/Revenue | 2.702 |
| Enterprise Value/EBITDA | -3.765 |
Trading Information
Biomerica Stock Price History
| Beta (5Y Monthly) | -0.637676 |
| 52-Week Change | -43.53% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.25 USD |
| 52 Week Low | 1.08 USD |
| 50-Day Moving Average | 1.47 USD |
| 200-Day Moving Average | 2.77 USD |
BMRA Share Statistics
| Avg. Volume (3 month) | 40.48K USD |
| Avg. Daily Volume (10-Days) | 31.01K USD |
| Shares Outstanding | 16.82M |
| Float | 15.58M |
| Short Ratio | 8.32 |
| % Held by Insiders | 7.14% |
| % Held by Institutions | 25.67% |
| Shares Short | 324.05K |
| Short % of Float | 2.06% |
| Short % of Shares Outstanding | 1.92% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | May 31, 2023 |
Profitability
| Profit Margin | -74.55% |
| Operating Margin (ttm) | -74.93% |
| Gross Margin | 10.89% |
| EBITDA Margin | -71.76% |
Management Effectiveness
| Return on Assets (ttm) | -34.64% |
| Return on Equity (ttm) | -90.28% |
Income Statement
| Revenue (ttm) | 9.53M USD |
| Revenue Per Share (ttm) | 0.72 USD |
| Quarterly Revenue Growth (yoy) | -85.50% |
| Gross Profit (ttm) | 2.98M USD |
| EBITDA | -6841076 USD |
| Net Income Avi to Common (ttm) | -7106844 USD |
| Diluted EPS (ttm) | -0.6 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.35M USD |
| Total Cash Per Share (mrq) | 0.2 USD |
| Total Debt (mrq) | 1.18M USD |
| Total Debt/Equity (mrq) | 19.69 USD |
| Current Ratio (mrq) | 4.647 |
| Book Value Per Share (mrq) | 0.444 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8768901 USD |
| Levered Free Cash Flow (ttm) | -6068858 USD |
Profile of Biomerica
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 17571 Von Karman Avenue |
| ZIP | 92614 |
| Phone | 949 645 2111 |
| Website | https://www.biomerica.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 64 |
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; Helicobacter pylori test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Q&A For Biomerica Stock
What is a current BMRA stock price?
Biomerica BMRA stock price today per share is 0.83 USD.
How to purchase Biomerica stock?
You can buy BMRA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biomerica?
The stock symbol or ticker of Biomerica is BMRA.
Which industry does the Biomerica company belong to?
The Biomerica industry is Medical Devices.
How many shares does Biomerica have in circulation?
The max supply of Biomerica shares is 16.82M.
What is Biomerica Price to Earnings Ratio (PE Ratio)?
Biomerica PE Ratio is now.
What was Biomerica earnings per share over the trailing 12 months (TTM)?
Biomerica EPS is -0.38 USD over the trailing 12 months.
Which sector does the Biomerica company belong to?
The Biomerica sector is Healthcare.
Biomerica BMRA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}